A detailed history of Omnia Family Wealth, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Omnia Family Wealth, LLC holds 3,839 shares of ABBV stock, worth $658,465. This represents 0.33% of its overall portfolio holdings.

Number of Shares
3,839
Previous 3,496 9.81%
Holding current value
$658,465
Previous $541,000 29.21%
% of portfolio
0.33%
Previous 0.28%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$159.82 - $182.1 $54,818 - $62,460
343 Added 9.81%
3,839 $699,000
Q4 2023

Feb 05, 2024

SELL
$137.6 - $154.97 $45,683 - $51,450
-332 Reduced 8.67%
3,496 $541,000
Q3 2023

Nov 01, 2023

BUY
$133.59 - $154.65 $47,691 - $55,210
357 Added 10.29%
3,828 $570,000
Q2 2023

Jul 31, 2023

SELL
$132.51 - $164.9 $22,659 - $28,197
-171 Reduced 4.7%
3,471 $467,000
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $16,485 - $18,985
114 Added 3.23%
3,642 $580,000
Q4 2022

Jan 31, 2023

BUY
$138.31 - $165.87 $7,883 - $9,454
57 Added 1.64%
3,528 $570,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $30,355 - $37,662
-230 Reduced 6.21%
3,471 $563,000
Q4 2021

Feb 04, 2022

BUY
$107.43 - $135.93 $23,312 - $29,496
217 Added 6.23%
3,701 $501,000
Q4 2020

Feb 08, 2021

SELL
$80.49 - $108.67 $16,097 - $21,734
-200 Reduced 5.43%
3,484 $373,000
Q2 2020

Aug 04, 2020

BUY
$73.37 - $98.18 $660 - $883
9 Added 0.24%
3,684 $361,000
Q1 2020

May 05, 2020

BUY
$64.5 - $97.79 $12,900 - $19,558
200 Added 5.76%
3,675 $280,000
Q3 2019

Nov 12, 2019

SELL
$62.98 - $75.72 $1,133 - $1,362
-18 Reduced 0.52%
3,475 $263,000
Q1 2018

May 11, 2018

SELL
$92.01 - $123.21 $29,351 - $39,303
-319 Reduced 8.37%
3,493 $331,000
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $28,569 - $31,328
319 Added 9.13%
3,812 $369,000
Q3 2017

Nov 14, 2017

SELL
$69.85 - $89.22 $11,036 - $14,096
-158 Reduced 4.33%
3,493 $310,000
Q2 2017

Aug 10, 2017

BUY
N/A
3,651
3,651 $265,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $303B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Omnia Family Wealth, LLC Portfolio

Follow Omnia Family Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Omnia Family Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Omnia Family Wealth, LLC with notifications on news.